Cite
APA Citation
Moser, S., Kozbial, K., Laferl, H., Schütz, A., Reiberger, T., Schwabl, P., Gutic, E., Schwanke, C., Schubert, R., Luhn, J., Lang, T., Schleicher, M., Steindl-Munda, P., Haltmayer, H., Ferenci, P., & Gschwantler, M. (n.d.). efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease. European journal of gastroenterology & hepatology, 30(3), . http://access.bl.uk/ark:/81055/vdc_100074563590.0x000046